Jackson Heart Study (JHS) of Cardiovascular Diseases in African Americans (JHS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00005485|
Recruitment Status : Unknown
Verified April 2016 by National Heart, Lung, and Blood Institute (NHLBI).
Recruitment status was: Active, not recruiting
First Posted : May 26, 2000
Last Update Posted : April 28, 2016
|Condition or disease|
|Cardiovascular Diseases Heart Diseases Atherosclerosis Coronary Disease Hypertension Cerebrovascular Disorders|
Heart disease and stroke remain the first and third leading killers of all Americans, with a disproportionate share of the burden borne by African Americans. Cardiovascular and total mortality are known to be higher among African Americans than among white Americans, but reasons for these differences remain unknown. In addition, well-documented declines in CVD and coronary disease mortality in the past three decades have not been shared equally between blacks and whites. Age-adjusted death rates were identical in both groups in 1980, but by 1994 the rate among African Americans was 14% higher than in whites. The race difference in magnitude of coronary heart disease (CHD) mortality is greater in women than men and higher in middle age, such that CHD deaths tend to occur in blacks about 5 years earlier than in whites. Excess cerebrovascular disease incidence and mortality in blacks are even greater than the differences noted in CHD.
Cardiovascular mortality rates in Mississippi, which are approximately 25% higher than the United States average, are the highest in the United States for all race-sex groups. Age-adjusted CVD mortality for African American women in Mississippi was 75% higher than in white women in 1994. The mortality for African American men was 47% higher than in white men.
Prevalence of hypertension is nearly 40% greater in African Americans than in whites and its sequelae are more frequent and severe. Evidence of target organ damage such as renal failure and left ventricular hypertrophy is more common in black than white hypertensives at comparable levels of blood pressure. Many risk factors are also more common in blacks, including diabetes, high serum lipoprotein levels [Lp(a)], and obesity (in women). Other risk factors, such as elevated total cholesterol, reduced high-density lipoprotein (HDL)-cholesterol, and heavy cigarette smoking, are more common in whites.
The Jackson Heart Study (JHS) initial examination, which began in the fall of 2000, included men and women ages 35 to 84, and took 3 years to complete. The coordinating center, located at Jackson State University, collects and analyzes data. The undergraduate training center at Tougaloo College offers coursework to students in public health and epidemiology, and provides practical experience in health research to prepare them for potential careers in these fields. The exam center at the University of Mississippi is responsible for recruiting participants and conducting examinations. JHS is uniquely positioned to answer key questions regarding the excess burden of CVD among African Americans and to address the critical shortage of minority investigators trained in epidemiology and prevention. These questions will be answered by incorporating state-of-the-art physiologic and epidemiologic methods in a stable population-based minority cohort, providing research experience, and building research capabilities at minority institutions. The Second Exam began in September 2005.
|Study Type :||Observational|
|Actual Enrollment :||5306 participants|
|Official Title:||Environmental and Genetic Factors That Influence Cardiovascular Disease in African Americans|
|Study Start Date :||September 2000|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005485
|United States, Mississippi|
|Jackson, Mississippi, United States, 39174|
|University of Mississippi Medical Center Department of Medicine|
|Jackson, Mississippi, United States, 39213|
|Jackson State University|
|Jackson, Mississippi, United States, 39217|
|Principal Investigator:||Asoka Srinivasan, PhD||Tougaloo College|
|Principal Investigator:||Donna Antone-LaVigne, MPH, PhD||Jackson State University|
|Principal Investigator:||Marinelle Payton, MD, PhD||Jackson State University|
|Study Director:||Adolfo Correa, MD, PhD, MBA||University of Mississippi Medical Center|